Implementation of cardiovascular secondary prevention guidelines in clinical practice: A nationwide survey in Italy

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 2, 2012, Pages 149-153

  Perrone Filardi, P ^a   Poli, A ^b   Ambrosio, G ^c   Proto, C ^d   Chimini, C ^d   Chiariello, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d Sant'Anna Institute   (Italy)

Author keywords

Cardiovascular risk factors; Prevention guidelines; Secondary prevention

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; INTERVENTION STUDY; INTERVIEW; ITALY; LIFESTYLE; MALE; METHODOLOGY; MIDDLE AGED; NUTRITION; PRACTICE GUIDELINE; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GUIDELINES AS TOPIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; INTERVENTION STUDIES; INTERVIEWS AS TOPIC; ITALY; LIFE STYLE; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION;

EID: 84856593483     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.05.009     Document Type: Article

References (15)

1. Unal B., Critchley J.A., Capewell S. Modelling the decline in coronary heart disease deaths in England and Wals, 1981-2000: comparing contributions from primary prevention and secondary prevention. BMJ 2005, 331:614-619.
2. Ford E.S., Ajani U.A., Croft J.B., Critchley J.A., Labarthe D.R., Kottke T.E., et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007, 356:2388-2398.
3. Lenfant C. Clinical research to clinical practice. Lost in translation?. N Engl J Med 2003, 349:868-874.
4. Muller-Nordhorn J., Binting S., Roll S., Willich S.N. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 2008, 29:1316-1326.
5. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al, European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Network (EHN); European Atherosclerosis Society (EAS). European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007; 14:S1-S113.
6. Katseva K., Wood D., De Backer G., De Bacquer D., Pyorala K., Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIE I, II and III surveys in eight European countries. Lancet 2009, 373:929-940. for the EUROASPIRE Study Group.
7. National Cholesterol Education Program (NCEP) Third report of the National Cholesterol Education Program (NCEP) expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation 2002, 106:3143-3421. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
8. Waters D.D., Brotons C., Chiang C.W., Ferrieres J., Foody J.A., Verdejo J., et al. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation 2009, 120:28-34. for the Lipid Assessment Project 2 Investigators.
9. Atela V., Brady A., Catapano A., Critchley J., Graham I.M., Hobbs F.D.R., et al. Bridging science and health policy in cardiovascular disease: focus on lipid management. Atheroscler Suppl 2009, 10:3-21.
10. Yach D., Hawkes C., Gould C.L., Hofman K.J. The global burden of chronic disease. Overcoming impediments to prevention and control. J Am Med Assoc 2004, 291:2616-2622.
11. Schroeder S.A. We can do better. Improving the health of the American people. N Engl J Med 2007, 357:1221-1228.
12. Balkau B., Deanfield J.E., Despres J.P., Bassand J.P., Fox K.A.A., Smith S.C., et al. International day for the evaluation of abdominal obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 1,68,000 primary care patients in 63 countries. Circulation 2007, 116:1942-1951.
13. de Velasco J.A., Cosin J., Lopez-Sendon J.L., de Teresa E., de Oya M., Sellers G. Nuevos datos sobre la prevencion secundaria de infarto de miocardio en Espana- Resultados del studio PREVESE II. Rev Esp Cardiol 2002, 55:801-808. for the PREVESE II Study Investigators.
14. Reiner Z., Mihatov S., Milicic D., Bergovec M., Planinc D. Treatment and secondary prevention of ischaemic coronary events in Croatia (TASPIC-CRO study). Eur J Cardiovasc Prev Rehabil 2006, 13:646-654. on behalf of the TESPIC-CRO Study Group Investigators.
15. Rapezzi C., Biagini E., Bellis P., Cafiero M., Velassi M., Ceriello A., et al. Exploring the gap between national cholesterol education program guidelines and clinical practice in secondary care: results of a cross-sectional study involving over 10,000 patients followed in different specialty settings across Italy. J Cardiovasc Med 2008, 9:878-887. for the EASY Investigators.